{"id":4029,"date":"2010-05-24T10:00:46","date_gmt":"2010-05-24T18:00:46","guid":{"rendered":"http:\/\/vaccineresistancemovement.org\/?page_id=4029"},"modified":"2016-02-08T22:12:17","modified_gmt":"2016-02-09T06:12:17","slug":"wire2","status":"publish","type":"page","link":"https:\/\/vaccineresistancemovement.org\/?page_id=4029","title":{"rendered":"VRM Wire2"},"content":{"rendered":"

\"VRM\"<\/p>\n

BREAKING <\/span><\/span> NEWS: New Study confirms Dr. Andrew Wakefield’s findings <\/span><\/span><\/p>\n

\"wakefield_g_k\"Just as the Press moves on from vilifying Dr. Wakefield a new UK study out quietly confirms his research linking Autism & Inflammatory Bowel Disease. The research identifies a characteristic chemical signature\/marker (metabolic abnormalities) in their urine. “The signature that comes up is related to gut bacteria,” says Dr. Nicholson of Imperial College London.
\nhttp:\/\/www.newscientist.com\/article\/dn19011-gut-bacteria-may-contribute-to-autism.html?DCMP=OTC-rss&nsref=online-news<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING <\/span><\/span> NEWS: The World Health Organization\u2019s Secret Emergency Committee on Pandemic planning was also paid by Big Pharma \u2013 fueling speculation that WHO Director General Dr. Margaret Chan may step down<\/span><\/span><\/p>\n

\"Dr.Chan\"According to the British Medical Journal a secret Emergency Committee advising the World Health Organization on planning for an influenza pandemic had done paid work for pharmaceutical\u00a0 firms that stood to gain from the guidance they were preparing, but the conflicts of interest have never been publicly disclosed.
\n<\/strong><\/p>\n

\u201cThe secrecy of the committee is fueling conspiracy theories, particularly around the activation of dormant pandemic vaccine contracts. A key question will be whether the pharmaceutical companies, which had invested around $4bn in developing the swine flu vaccine, had supporters inside the emergency committee, who then put pressure on WHO to declare a pandemic. It was the declaring of the pandemic that triggered the contracts.\u201c<\/strong><\/p>\n

BMJ editor Dr Fiona Godlee said delegates at the European meeting called for Dr Margaret Chan to resign as WHO director general. \u201cIt may come to that,\u201d she commented on Twitter.
\nhttp:\/\/www.6minutes.com.au\/articles\/z1\/view.asp?id=518413<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING <\/span><\/span> NEWS: World Health Organization & Vaccine Manufacturers Implicated In Massive H1N1 Financial Scam Involving Kickbacks & Cover-ups<\/span><\/span><\/p>\n

\"BMJLG\"A stunning new report reveals that top scientists who convinced the World Health Organization to declare H1N1 a global pandemic held close financial ties to the drug companies that profited from the sale of those vaccines. This report, published in the British Medical Journal, exposes the hidden ties that drove WHO to declare a pandemic, resulting in billions of dollars in profits for vaccine manufacturers. <\/strong><\/p>\n

“For WHO, its credibility has been badly damaged. WHO must act now to restore its credibility.” <\/strong>Fiona Godlee, Editor of British Medical Journal (BMJ)<\/strong><\/p>\n

\"pharma“The idea that we declared a pandemic when there wasn’t a pandemic is both historically inaccurate and downright irresponsible,” said WHO spokesman Gregory Hartl in a telephone interview. “There is no doubt that this was a pandemic. To insinuate that this was not a pandemic is very disrespectful to the people who died from it.” WHO spokesman Gregory Hartl
\nhttp:\/\/www.naturalnews.com\/028936_WHO_vaccines.htm<\/a><\/strong><\/p>\n

“Potential conflicts of interest are inherent in anyrelationship between a normative and health development agency,like WHO, and a profit-driven industry. Similar considerationsapply when experts advising the Organization have professionallinks with pharmaceutical companies. Numerous safeguards arein place to manage possible conflicts of interest or their perception.” WHO SPIN<\/strong><\/p>\n

“The problem is not so much that communicating uncertainty is difficult, but that uncertainty was not communicated. There was no scientific basis for the WHO\u2019s estimate of 2 billion for likely H1N1 cases, and we knew little about the benefits and harms of the vaccination. The WHO maintained this 2 billion estimate even after the winter season in Australia and New Zealand showed that only about one to two out of 1000 people were infected. Last but not least, it changed the very definition of a pandemic.” Gerd Gigerenzer, director of the Centre for Adaptive Behaviour and Cognition at the Max Planck Institute in Germany<\/strong><\/p>\n

Influenza Pandemic Plan: The Role of WHO and Guidelines for National and Regional Planning
\nhttp:\/\/www.wpro.who.int\/NR\/rdonlyres\/A7C42115-DF0F-48CF-82AF-DDE0D734994E\/0\/InfluenzaPandemicPlan.pdf<\/a><\/strong><\/p>\n

\"SWINE_468x286\"Objectives of Influenza Pandemic Plan: To “take measures to encourage the pharmaceutical industry to plan its vaccine\/antivirals production capacity in advance”, to “encourage and support research and development of pandemic vaccine” and to “develop a policy for antiviral stockpiling.” It also added that government representatives needed to know that “influenza vaccination and use of antivirals is beneficial and safe.” It said that the group provided “evidence based, palatable information”; and also “networking\/exchange with other stakeholders (eg, with industry in order to establish pandemic vaccine and antivirals contracts).<\/strong><\/p>\n

Scientists on the double dipping payroll include:<\/strong><\/p>\n

1) Dr.Ren\u00e9 Snacken\/Belgian Ministry of Public Health, WHO Division of Viral Diseases (1998), Co-author of ‘Influenza Pandemic Plan: The Role of WHO and Guidelines for National and Regional Planning’ (1999), also funded researcher for Roche (Tamiflu).<\/strong><\/p>\n

2) Dr Daniel Lavanchy\/Co-author of ‘Influenza Pandemic Plan: The Role of WHO and Guidelines for National and Regional Planning’ (1999),\u00a0 appeared at a Roche sponsored symposium in 1998 while employed at WHO Division of Viral Diseases.<\/strong><\/p>\n

3) Professor Karl Nicholson\/Leicester University, UK, Member of The European Scientific Working Group on Influenza (ESWI) which collaborated with WHO on ‘Influenza Pandemic Plan: The Role of WHO and Guidelines for National and Regional Planning’, also conducted a randomised controlled trial on oseltamivir (Tamiflu) supported by Roche.<\/strong><\/p>\n

4) Professor Abe Osterhaus\/Erasmus University, Netherlands, Member of The European Scientific Working Group on Influenza (ESWI) which collaborated with WHO on ‘Influenza Pandemic Plan: The Role of WHO and Guidelines for National and Regional Planning’, also conducted a randomised controlled trial on oseltamivir (Tamiflu) supported by Roche.<\/strong><\/p>\n

WHO for years had defined pandemics as outbreaks causing “enormous numbers of deaths and illness” but in early May 2009 it removed this phrase\u2014describing a measure of severity\u2014from the definition.<\/strong><\/p>\n

DEFINITION OF PANDEMIC (before May 2009) – “An influenza pandemic occurs when a new influenza virus appears against which the human population has no immunity, resulting in several, simultaneous epidemics worldwide with enormous numbers of deaths and illness. With the increase in global transport and communications, as well as urbanization and overcrowded conditions, epidemics due the new influenza virus are likely to quickly take hold around the world.”
\nhttp:\/\/web.archive.org\/web\/20050207101237\/http:\/www.who.int\/csr\/disease\/influenza\/pandemic\/en\/<\/a><\/strong><\/p>\n

\"pandemic-map\"DEFINITION OF A PANDEMIC (after May 2009) – “A disease epidemic occurs when there are more cases of that disease than normal. A pandemic is a worldwide epidemic of a disease. An influenza pandemic may occur when a new influenza virus appears against which the human population has no immunity. With the increase in global transport, as well as urbanization and overcrowded conditions in some areas, epidemics due to a new influenza virus are likely to take hold around the world, and become a pandemic faster than before. WHO has defined the phases of a pandemic to provide a global framework to aid countries in pandemic preparedness and response planning. Pandemics can be either mild or severe in the illness and death they cause, and the severity of a pandemic can change over the course of that pandemic.”
\nhttp:\/\/www.who.int\/csr\/disease\/influenza\/pandemic\/en\/<\/a><\/strong><\/p>\n

“A defining characteristic of a pandemic is the almost universal vulnerability of the world\u2019s population to infection. Not all people become infected, but nearly all people are at risk.” Dr. Margaret Chan, Director-General\/WHO
\nhttp:\/\/www.who.int\/dg\/speeches\/2009\/62nd_assembly_address_20090518\/en\/<\/a><\/strong><\/p>\n

British Medical Journal: Original Article
\nhttp:\/\/www.bmj.com\/cgi\/content\/full\/340\/jun03_4\/c291<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING <\/span><\/span> NEWS: Drug Companies Impose Economic Blackmail Suspending Shipments to Greece as Profits Plunge <\/span><\/span><\/p>\n

\"Euro\"Danish Pharmaceutical Giants Leo Pharma & Novo Nordisk are withholding Insulin & Blood-Clotting supplies from Greece in retaliation for a 25% price reduction. Greek government officials believe the Danish companies are blackmailing Athens because they monopolise the market with certain key drugs.\u00a0 According to Stefanos Combinos, the director general of the economy ministry, Greece is one of the three most expensive countries in Europe for medicines.
\nhttp:\/\/news.bbc.co.uk\/2\/hi\/world\/europe\/10193799.stm<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING <\/span><\/span> NEWS: British National Health Service Executives Earning Huge Salaries Despite ‘So Called’ Necessity For Drastic Budget Cuts<\/span><\/span><\/p>\n

\"Nicholson\"David Nicholson, the British National Health Service Chief Executive earns between \u00a3255,000 & \u00a3259,999 (approximately $520,000) annually. Gabriel Scally, NHS regional director of public health earns between \u00a3200,000 – \u00a3204,999. In total 171 NHS executives earn from \u00a3150,000 to \u00a3200,000. This despite a 21% cut in health services & the sudden firing of 100 hospital workers.
\nhttp:\/\/www.healthcarerepublic.com\/news\/bulletin\/DAILY_NEWS\/article\/1006830\/?DCMP=EMC-BreakingnewsfromHealthcareRepublic<\/a><\/strong><\/p>\n

\"nationallogo\"The National Health Service budget for building and hospitals and buying medical equipment cut by 21%
\nhttp:\/\/www.telegraph.co.uk\/news\/newstopics\/politics\/7150026\/NHS-building-budget-cut-by-21-per-cent.html<\/a>
\n<\/strong><\/p>\n

100 hospital jobs go in budget cuts
\nhttp:\/\/www.independent.co.uk\/news\/uk\/100-hospital-jobs-go-in-budget-cuts-1541513.html<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING <\/span><\/span> NEWS: California County Sues GlaxoSmithKline Over Diabetes Drug ‘Avandia’ (linked to heart attacks) <\/span><\/span><\/p>\n

\"avandia\"“GSK’s unlawful conduct has cost patients, their insurers and government payers millions of dollars, and it has caused needless suffering to thousands of Californians,” explained Miguel Marquez, Santa Clara County’s acting county counsel. “This is precisely the sort of corporate malfeasance that California law prohibits.”\u00a0 GSK has denied all allegations and continues to claim the FDA-approved drug is safe, despite recent reports that show the drug is responsible for causing thousands of heart attacks. The Senate Committee Report revealed back in February proved that GSK knew about the risks associated with Avandia for years but did nothing about it.
\nhttp:\/\/www.naturalnews.com\/028918_false_advertising_Big_Pharma.html<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: Melbourne Study Finds Thimerosal in \u201cMercury Free\u201d Vaccine \u2018Infanrix hexa\u2122\u2019<\/strong><\/p>\n

\"Infanrix2\"<\/strong><\/p>\n

\u20188 vaccines administered to children under the age of 5 yr were assessed for Mercury (Hg) content via a DMA-80 direct mercury analyzer. 7 of the 8 vaccines contained no detectable levels of Hg (less than 1 ppb); however, 1 vaccine (Infanrix hexa) tested positive for Hg at 10 ppb. The result was confirmed and validated by retesting the original sample.<\/strong><\/p>\n

Despite the removal of the mercury (Hg)-based preservative Thimerosal from vaccines listed on the Australian Immunization Program Schedule for children, concerns remain among some researchers and parents for the safety of the present schedule, in part due to a fear of residual trace levels of Hg.\u2019
\nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20391108<\/a><\/strong><\/p>\n

INFANRIX hexa\u2122 \u2013 Given at 6 weeks, 3 months, & 5 months \u2013 Combined diphtheria & tetanus toxoids, acellular pertussis, hepatitis B\/recombinant, inactivated poliomyelitis & adsorbed conjugated Haemophilus influenzae type b vaccine)<\/strong><\/p>\n

NOTE: This vaccine is a deadly cocktail containing multiple live viruses, Aluminum, Neomycin & Polymixin (antibiotics associated with Kidney Failure, hazardous to fetus), 2 forms of detergent including Polysorbate 80 (Tween80\u2122) which can cause severe allergic reactions, including anaphylaxis) & Formaldehyde (used as a preservative & disinfectant, binds to the proteins in your DNA, known to cause cancer, chronic bronchitis, eye irritation when exposed to the body\u2019s immune system)
\nhttp:\/\/gsk.ca\/english\/docs-pdf\/Infanrix-hexa_PM_20080718_EN.pdf<\/a><\/strong><\/p>\n

http:\/\/www.immune.org.nz\/site_resources\/Parents\/Schedule%20Change%202008\/DTaP-P-2857_Introducing_Infanrix_2_IMAC_March_2008.pdf<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: \u2018Porcine Circovirus 2\u2019 Found In Merck\u2019s \u2018Rota Teq\u2019 Diarrhea Vaccine For Babies<\/strong><\/p>\n

\"Rotavirus_vaccine\"(PCV2) is a DEADLY pig virus that causes very severe disease in infant pigs, including: Wasting and failure to thrive, Immune suppression, Respiratory problems, Kidney, brain and reproductive problems, Death. Still on the market. Warn parents not to get this shot now.<\/strong><\/p>\n

\u201cSo, the problem we have is that babies are swallowing basically parts of a lethal pig virus, and that\u2019s why we believe Merck should voluntarily take RotaTeq vaccine off the market until they can clean the vaccine up, and put a vaccine on the market that is not contaminated.\u201d Barbara Loe Fisher<\/strong>
\nhttp:\/\/articles.mercola.com\/sites\/articles\/archive\/2010\/06\/01\/barbara-loe-fisher-may-21-interview.aspx<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: Chemtrail Symposium: Belgium\/May 29th, 2010, Organized by The Belfort\u2019s group, Citizens In Action<\/strong><\/p>\n

\"masks_dees\"Chemtrail symposium: Belgium, May 29th \u2013 PART 1
\nhttp:\/\/www.ustream.tv\/recorded\/7290769
\n<\/a>
\nChemtrail symposium: Belgium, May 29th \u2013 PART 2
\nhttp:\/\/www.ustream.tv\/recorded\/7293422<\/a><\/strong><\/p>\n

Chemtrail symposium: Belgium, May 29th \u2013 PART 3
\nhttp:\/\/www.ustream.tv\/recorded\/7299427<\/a><\/strong><\/p>\n

Chemtrail symposium: Belgium, May 29th \u2013 PART 4
\nhttp:\/\/www.ustream.tv\/recorded\/7304674<\/a><\/strong><\/p>\n

VRM: Morgellons Syndrome & Chemtrails
\nhttp:\/\/vaccineresistancemovement.org\/?p=839<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: Meningitis Vaccine To Be Forced On 7th Graders & All College Students \u2013 Risk Assessment<\/strong><\/p>\n

\"MeningitisA substantial new Bill to require meningitis vaccine for 7th graders and ALL college students is gaining momentum in Albany, New York
\nhttp:\/\/www.healthfreedomusa.org\/?p=5472<\/a><\/strong><\/p>\n

Bill S7156 passed the Senate Health Committee and is due for a floor vote.<\/strong><\/p>\n

Bill A10313 will be voted on the Assembly Health Committee any given Tuesday.
\nhttp:\/\/www.ncsl.org\/IssuesResearch\/Health\/<\/a><\/strong>MeningitisLegislationandLaws\/tabid\/13960\/Default.aspx<\/a><\/strong><\/p>\n

Assuming this Bill is rammed through the Senate & Health Committee which seems inevitable the public must be alerted immediately to the serious risks associated with this vaccine.<\/strong> If New York buckles under pressure then other States & countries around the world are sure to follow. <\/strong>There are 3 Meningitis Vaccines being promoted by the WHO & CDC for distribution in this campaign including:<\/strong><\/p>\n

1) MENACTRA (Manufactured by Sanofi Pasteur Inc.)<\/strong><\/p>\n

\"Menactra-300x300\"Menactra\u00ae, Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, is a sterile, intramuscularly administered vaccine that contains Neisseria meningitidis serogroup A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid protein. N meningitidis A, C, Y and W-135 strains are cultured on Mueller Hinton agar (1) and grown in Watson Scherp(2) media. The polysaccharides are extracted from the N meningitidis cells and purified by centrifugation, detergent precipitation, alcohol precipitation, solvent extraction and diafiltration. To prepare the polysaccharides for conjugation, they are depolymerized, derivatized, and purified by diafiltration. Corynebacterium diphtheriae cultures are grown in a modified Mueller and Miller medium (3) and detoxified with formaldehyde. The diphtheria toxoid protein is purified by ammonium sulfate fractionation and diafiltration.
\nhttp:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM131170.pdf<\/a><\/strong><\/p>\n

Package Insert: General Warnings \u2013
\n<\/strong><\/p>\n

NURSING MOTHERS: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Menactra vaccine is administered to a nursing woman.<\/strong><\/p>\n

PEDIATRIC USE: Safety and effectiveness of Menactra vaccine in children below the age of 2 years have not been established.<\/strong><\/p>\n

GERIATRIC USE: Safety and effectiveness of Menactra vaccine in adults older than 55 years have not been established<\/strong><\/p>\n

CARCINOGENESIS, MUTAGENESIS \u2013 IMPAIRMENT OF FERTILITY: Menactra vaccine has not been evaluated in animals for its carcinogenic or mutagenic potentials or for impairment of fertility.<\/strong><\/p>\n

CONTRAINDICATIONS: Known hypersensitivity to any component of Menactra vaccine including diphtheria toxoid, or a life-threatening reaction after previous administration of a vaccine containing similar components, are contraindications to vaccine administration.<\/strong><\/p>\n

GUILLAIN-BARRE SYNDROME<\/strong>: Guillain-Barr\u00e9 syndrome has been reported in temporal relationship following administration of Menactra vaccine. An evaluation of post-marketing adverse events suggests a potential for an increased risk of GBS following Menactra vaccination. Persons previously diagnosed with GBS should not receive Menactra vaccine.<\/strong><\/p>\n

LATEX: The stopper of the vial contains dry natural rubber latex, which may cause allergic reactions in latex-sensitive individuals. There is no latex in any component of the syringe.
\n<\/strong><\/p>\n

2) MENOMUNE (Manufactured by Sanofi Pasteur Inc.)<\/strong><\/p>\n

\"Sanofi_Pasteur-logo-1E51D9C735-seeklogo.com\"Menomune\u00ae \u2013 A\/C\/Y\/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, for subcutaneous use, is a freeze-dried preparation of the group-specific polysaccharide antigens from Neisseria meningitidis, Group A, Group C, Group Y and Group W-135. N meningitidis are cultivated with Mueller Hinton agar1 and Watson Scherp2 media. The purified polysaccharide is extracted from the Neisseria meningitidis cells and separated from the media by procedures which include centrifugation, detergent precipitation, alcohol precipitation, solvent or organic extraction and diafiltration.
\nhttp:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM131653.pdf<\/a><\/strong><\/p>\n

Package Insert: General Warnings \u2013<\/strong><\/p>\n

IT IS A CONTRAINDICATION TO ADMINISTER MENOMUNE \u2013 A\/C\/Y\/W-135 VACCINE TO INDIVIDUALS KNOWN TO BE SENSITIVE TO THIMEROSAL OR ANY OTHER COMPONENT OF THE VACCINE.<\/strong><\/p>\n

FOR INDIVIDUALS SENSITIVE TO THIMEROSAL, ADMINISTER THE ONE DOSE PACKAGE SIZE AND RECONSTITUTE WITH THE 0.78 ML VIAL OF DILUENT THAT CONTAINS NO PRESERVATIVE.<\/strong><\/p>\n

WARNING: This product contains dry natural latex rubber as follows: The stopper to the vial contains dry natural latex rubber.<\/strong><\/p>\n

If the vaccine is used in persons receiving immunosuppressive therapy, the expected immune response may not be obtained.<\/strong><\/p>\n

VACCINE INTERACTIONS \u2013 <\/strong>Menomune<\/strong> should NOT be given at the same time as whole-cell pertussis or whole-cell typhoid vaccines due to combined endotoxin content.20,21<\/strong><\/p>\n

PRECAUTIONS: EPINEPHRINE INJECTION (1:1000) MUST BE IMMEDIATELY AVAILABLE TO COMBAT UNEXPECTED ANAPHYLACTIC OR OTHER ALLERGIC REACTIONS.<\/strong><\/p>\n

DRUG INTERACTIONS: If Menomune \u2013 A\/C\/Y\/W-135 vaccine is administered to immunosuppressed persons or persons receiving immunosuppressive
\ntherapy, an adequate immunologic response may not be obtained.<\/strong><\/p>\n

CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY: Menomune \u2013 A\/C\/Y\/W-135 vaccine has not been evaluated in animals for its carcinogenic, mutagenic potentials or impairment
\nof fertility.<\/strong><\/p>\n

PREGNANCY CATEGORY C: Animal reproduction studies have not been conducted with Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135. It is also not known whether Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Meningococcal Polysaccharide Vaccine, Groups A, C, Y
\nand W-135 should be given to a pregnant woman only if clearly needed.<\/strong><\/p>\n

NURSING MOTHERS: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Menomune \u2013 A\/C\/Y\/W-135 vaccine is administered to a nursing woman.<\/strong><\/p>\n

PEDIATRIC USE SAFETY AND EFFECTIVENESS OF MENOMUNE \u2013 A\/C\/Y\/W-135 VACCINE IN CHILDREN BELOW THE AGE OF 2 YEARS HAVE NOT BEEN ESTABLISHED.
\n<\/strong><\/p>\n

3) MENVEO (Manufatured by Novartis Vaccines and Diagnostics, Inc.)<\/strong><\/p>\n

\"menveo\"Menveo\u00ae [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine] is a sterile liquid vaccine administered by intramuscular injection that contains N. meningitidis serogroup A, C, Y and W-135 oligosaccharides conjugated individually to Corynebacterium diphtheriae CRM197 protein. The polysaccharides are produced by bacterial fermentation of N. meningitidis (serogroups A, C, Y or W-135). N. meningitidis strains A, C, Y and W-135 are each cultured and grown on Franz Complete medium and treated with formaldehyde. MenA, MenW-135 and MenY polysaccharides are purified by several extraction and precipitation steps. MenC polysaccharide is purified by a combination of chromatography and precipitation steps.
\nThe protein carrier (CRM197) is produced by bacterial fermentation and is purified by a series of chromatography and ultrafiltration steps. C. diphtheriae is cultured and grown on CY medium containing yeast extracts and amino acids.
\nhttp:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM201349.pdf<\/a><\/strong><\/p>\n

*NOTE: C. diphtheriae is cultured and grown on CY medium containing yeast extracts refers to genetically modified yeast. Anyone with an allergy to gluten will be adversely affected by this process.<\/strong><\/p>\n

Package Insert: General Warnings \u2013<\/strong><\/p>\n

PRECAUTIONS: Management of Acute Allergic Reactions Appropriate medical treatment must be available should an acute allergic reaction, including an anaphylactic reaction, occur following administration of MENVEO.<\/strong><\/p>\n

SYNCOPE: Because vaccinees may develop syncope, sometimes resulting in falling with injury, observation for 15 minutes after administration is recommended. Syncope, sometimes associated with tonic-clonic movements and other seizure-like activity, has been reported following vaccination with MENVEO. When syncope is associated with tonic-clonic movements, the activity is usually transient and typically responds to restoring cerebral perfusion by maintaining a supine or Trendelenburg position.<\/strong><\/p>\n

Altered Immunocompetence Safety and effectiveness of MENVEO have not been evaluated in immunocompromised persons. If MENVEO is administered to immunocompromised persons, including those receiving immunosuppressive therapy, the expected immune response may not be obtained.<\/strong><\/p>\n

GUILLAIN-BARRE SYNDROME: Following vaccination with a U.S.-licensed meningococcal quadrivalent polysaccharide conjugate vaccine, an evaluation of post-marketing adverse events suggested a potential for an increased risk of Guillain-Barr\u00e9 Syndrome (GBS). Data are not available to evaluate the potential risk of GBS following administration of MENVEO.<\/strong><\/p>\n

BLEEDING DISORDERS: MENVEO should not be administered to persons with any bleeding disorder, or persons receiving anticoagulant therapy, unless the potential benefit outweighs the risk of administration.<\/strong><\/p>\n

Complete list of Meningitis Vaccines Found Here
\nhttp:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm093830.htm<\/a><\/strong><\/p>\n

MENINGITIS: THE FACTS\u00a0 \u2013 These days, when a vaccinee develops poliomyelitis, it may not be called poliomyelitis; instead, it may be called viral or aseptic meningitis, ascending paralysis (Guillain-Barre syndrome), cerebral palsy (over 75 per cent of cases are not diagnosed at birth but after six months) or other such names. According to MMWR (1997; 32[29]:384-385), there are 30,000 to 50,000 cases of aseptic meningitis every year in the United States. Considering that the vast majority (99 per cent) of the reported cases in the pre-vaccine era were non-paralytic and would have corresponded to aseptic or aviral meningitis, then vaccination has actually increased the incidence of poliomyelitis. In the pre-vaccine era, such high numbers only occurred in some epidemics. Now, such numbers occur every year, year by year.
\nhttp:\/\/www.whale.to\/vaccines\/meningitis2.htm<\/a><\/strong><\/p>\n

The Department of Health has refused to carry out a review into the safety of the meningitis C vaccine despite fears it is unsafe. New figures show that almost 5,000 children have suffered adverse reactions to the vaccine since it was introduced. The Chiron jab was introduced in June of 2000, a year ahead of schedule, as a protection against the meningitis C strain. It has been given to 13m children and university students across the UK. But according to figures from the Medical Controls Agency there were 4,764 reports of adverse reactions to the vaccine up to the beginning of June. A further 10,202 suspected reactions have been reported while an investigation has been launched into the deaths of eight children to see if there is a link to the vaccine.
\nhttp:\/\/www.nccn.net\/~wwithin\/meningitisc.htm<\/a><\/strong><\/p>\n

\"AutismGRASSROOTS COMMUNITY ORGANIZING TO COUNTER LEGISLATION: Stop Stealth Mandatory Meningitis Vaccine Bill In New York. Come to Albany on Tuesday, June 1
\nhttp:\/\/capwiz.com\/a-champ\/issues\/alert\/?alertid=15089571<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: Vaccine Resistance Movement Founder Joel Lord Interviewed On Freedomizer Radio (begins at start of hour 3)<\/strong><\/p>\n

\u2018We the undersigned, as Freemen & Freewomen, do not recognize the authority of The World Health Organization (WHO) to mandate general forced vaccinations. Our bodies are sovereign territory and subject to our exclusive self-determination. Any attempted violation of this trust must be construed as a breach of said basic right. We are thus holding our elected Governments accountable in this defense with an issuance of notice: a preemptive Class Action Lawsuit to be served in the event our inalienable rights to choose are forsaken.\u2019 <\/strong><\/p>\n

\u2013 Excerpt from VRM Petition A UNIVERSAL DECLARATION OF RESISTANCE TO MANDATORY VACCINATIONS<\/a><\/strong><\/p>\n

http:\/\/www.blogtalkradio.com\/freedomizerradio\/2010\/05\/26\/proof-negative-show-real-patriot-news-<\/a><\/strong><\/p>\n

UPDATE: Vaccine Resistance Movement Founder Joel Lord interviewed<\/strong> (08\/09\/10). Topics include: Military\/Darpa enter Vaccine business, Vaccine scandals around the world, VRM Autism study, false flag Bio-Terrorism, The Rockefeller vision\/future now, GMO industry\/Vaccine hegemony \u2013 Starts at 58 minutes
\nhttp:\/\/www.blogtalkradio.com\/freedomizerradio\/2010\/09\/09\/proof-negative-show-real-patriot-news-<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: GMC Wolfpack Attempts to Slam The Door on Anti-Vaccine Movement \u2013 Britain Officially Bans Dr. Andrew Wakefield From Practicing Medicine In The UK<\/strong><\/p>\n

\"BritainGENERAL MEDICAL COUNCIL VERDICT: \u201cThe panel has determined that Dr Wakefield\u2019s name should be erased from the medical register. Dr Wakefield\u2019s continued lack of insight as to his misconduct serve only to satisfy the panel that suspension is not sufficient and that his actions are incompatible with his continued registration as a medical practitioner.\u201d<\/strong><\/p>\n

Terence Stephenson, president of the Royal College of Paediatrics and Child Health, said the false suggestion of a link between autism and the MMR vaccine had caused \u201cuntold damage\u201d to vaccination programs.<\/strong><\/p>\n

\u201cWe cannot stress too strongly that all children and young people should have the MMR vaccine. Overwhelming scientific evidence shows that it is safe,\u201d he said in a statement.<\/strong><\/p>\n

Wakefield defended his work, and said the GMC had sought to deny that the case against him was related to whether the vaccine was safe, and specifically, whether it caused autism.<\/strong><\/p>\n

\u201cEfforts to discredit and silence me through the GMC process have provided a screen to shield the government from exposure on the \u2026 MMR vaccine scandal,\u201d he said in a statement.
\nhttp:\/\/uk.reuters.com\/article\/idUKTRE64N1XB20100524<\/a><\/strong><\/p>\n

Wakefield said in January that the medical council\u2019s investigation was an effort to \u201cdiscredit and silence\u201d him to \u201cshield the government from exposure on the (measles) vaccine scandal.\u201d Appearing fromNew York on NBC\u2019s \u201cToday Show\u201d <\/a>on Monday, Wakefield described the British decision as \u201ca little bump on the road.\u201d He claimed the U.S. government has been settling cases of vaccine-induced autism since 1991. <\/strong><\/p>\n

Wakefield said the council\u2019s ruling against him had been \u201cmade from the outset\u201d and vowed to continue his research into the link between vaccines and autism. These parents are not going away<\/a>; the children are not going to go away and I most certainly am not going away,\u201d he said.
\nhttp:\/\/news.yahoo.com\/s\/ap\/20100524\/ap_on_sc\/eu_britain_autism_doctor<\/a><\/strong><\/p>\n

GMC OFFICIAL REPORT: http:\/\/www.gmc-uk.org\/Wakefield_SPM_and_SANCTION.pdf_32595267.pdf<\/a><\/strong><\/p>\n

\"GMC\"General Medical Council: Contact Info
\nhttp:\/\/www.gmc-uk.org\/about\/contacts.asp<\/a><\/strong><\/p>\n

Anyone living in the UK please consider flooding the GMC to voice your opinion on this ridiculous verdict.<\/strong><\/p>\n

GMC \u2013 Inside the UK: 0161 923 6602<\/strong><\/p>\n

GMC \u2013 Outside the UK: +44 161 923 6602<\/strong><\/p>\n

\u201cIf you tell a lie big enough and keep repeating it, people will eventually come to believe it. The lie can be maintained only for such time as the State can shield the people from the political, economic and\/or military consequences of the lie. It thus becomes vitally important for the State to use all of its powers to repress dissent, for the truth is the mortal enemy of the lie, and thus by extension, the truth is the greatest enemy of the State.\u201d Joseph Goebbels<\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: Conflict Of Interest Reveals The Real Reason Behind Attacks On Dr. Wakefield \u2013 The British Medical Journal \u2018The Lancet\u2019 Is In League With Glaxo-Smythe Kline (MMR Vaccine Manufacturer In UK Guilty Of Distributing Contaminated MMR Vaccine During The 1980\u2019s)<\/strong><\/p>\n

\"elsevier\"Sir Crispin Davis was appointed Chief Executive Officer of Reed Elsevier Group (which owns The Lancet) in September 1999. He is also: Non-executive director of GlaxoSmithKline.<\/strong><\/p>\n

MMR VACCINE TIMELINE: The mumps, measles and rubella vaccination, was introduced to Britain in 1988. Its original introduction was seriously marred by adverse reaction to the Urabi mumps strain in the vaccination. It was not until 1992 that the Department of Health, downplaying the serious adverse events that had occurred using this particular strain, took two of the MMR vaccines off the market while making low-key and somewhat mumbled explanations to the public. <\/strong><\/p>\n

COVER-UP: Following this major problem, the Department of Health and the successive governments were determined not to admit to any other problems in relation to this vaccination.
\nhttp:\/\/www.whale.to\/vaccine\/walker13.html<\/a><\/strong><\/p>\n

The British government continued to vaccinate with <\/strong>the two Urabi strain mumps MMR brands<\/strong> between 1988 and 1992, when they stopped using it, even though it had been rescinded by the Canadian government and found to be unsafe. However, the adverse reactions from Urabi were related to meningitis and not inflammatory bowel disease and regressive autism.
\nhttp:\/\/www.ageofautism.com\/2010\/04\/gmc-hearing-update.html<\/a><\/strong><\/p>\n

The whole weight of the case against Dr. Wakefield is built on discrediting his research. But now we know that Glaxo-Smythe Kline were in major damage control after their MMR vaccine, rejected by the Canadian Government for its bad track record yet approved for use by the British Health Authorities turned out to be tainted with Mumps. This resulted in an outbreak of Meningitis in the UK. They were determined to cover up the potential fallout from the scandal. <\/strong><\/p>\n

Ultimately the government would take the blame for its negligence in allowing a toxic vaccine to be knowingly distributed. According to their official contract GSK who be immune from prosecution in the event of adverse effects resulting from the shots.<\/strong><\/p>\n

Meanwhile Wakefield & his fellow researchers identified a major link between the Gut problems in children who had gotten the MMR shot with an upsurge in cases of Autism. This cast a huge spotlight on GSK & the British Government. <\/strong><\/p>\n

Initially the Lancet was quick to support Dr. Wakefield\u2019s work in 1998. However that was before their Chief Executive Officer stepped down. Enter Sir Crispin Davis who was appointed Chief Executive Officer of Reed Elsevier Group (which owns The Lancet) in September 1999. <\/strong>Co-incidentally he is also: Non-executive director of GlaxoSmithKline. As managing director he now had the power to simultaneously regulate Lancet policy & GSK strategy from behind the scenes.<\/strong><\/p>\n

As Autism rates continue to skyrocket the Government seems determined to shut the door on the whole Vaccine-Autism argument once and for all. They will offer instead another direction; and with it enough rabbit holes to keep the Medical Industry profits pouring in for generations to come. Leaving our children the burden of shame for our not having done enough now to reverse the tide and take back our sovereignty.<\/strong><\/p>\n

\u201cIt is time to rethink mental disorders, recognizing that these are disorders of brain circuits likely caused by developmental processes shaped by a complex interplay of genetics and experience,\u201d<\/strong><\/p>\n

America\u2019s top two mental health officials Insel and Wang point to two recent studies suggesting that autism, schizophrenia and bipolar disorder are hereditary in nature. And they say researchers are already seeing positive results in genetic research on fragile X syndrome, which carries important implications for understanding both autism and intellectual disability. New knowledge about the genetics behind fragile X led to quick trials of drugs which researchers say hold promise in treating the disorder.
\nhttp:\/\/www.disabilityscoop.com\/2010\/05\/18\/insel-mental-health-commentary\/8095\/<\/a><\/strong><\/p>\n

\"Davis\"Sir Crispin Davis: Biography
\nhttp:\/\/people.forbes.com\/profile\/crispin-davis\/37085<\/a>
\nhttp:\/\/business.timesonline.co.uk\/tol\/business\/industry_sectors\/media\/article4322496.ece<\/a><\/strong><\/p>\n

Reed Elsevier Board of directors (Publisher of The Lancet)
\nhttp:\/\/www.reed-elsevier.com\/annualreport08\/governance\/Pages\/directors.aspx<\/a><\/strong><\/p>\n

Glaxo-Smythe Kline: Board of Directors
\nhttp:\/\/www.gsk.com\/about\/boardofdirectors.htm<\/a><\/strong><\/p>\n

NOTE: If anyone should be on trial here it\u2019s Sir Crispin Davis. Another Big Pharma cover-up.<\/strong><\/p>\n

CONFLICTS OF INTEREST AMONGST REGULATORY AGENCIES COMMONPLACE: 4 out of 12 senior managers at the Irish Medicines Board (IMB) have a pharma background, including a former CEO who worked for a pharma company immediately before and after his time with the IMB. In total, 26% of IMB senior employees have pharma connections. <\/strong><\/p>\n

Conflicts of interest (COIs) appear to be a significant problem within the <\/strong>Medicines and Healthcare products Regulatory Agency (MHRA)<\/strong>, where not only are 28% of recent senior MHRA personnel found to have had a relationship with pharma companies, but of the agency\u2019s 63 expert advisors, 48 have personal interests, 32 have non-personal interests, and only 15 had no interests at all. There was a similar pattern amongst the chairs of their various Working Groups, Panels and Experts Advisory Groups. <\/strong><\/p>\n

Within the <\/strong>European Medicines Agency (<\/strong>EMEA), up-to-date declarations of interest are listed for approximately half of their \u2018experts\u2019. 73% of these COIs are considered \u2018high risk\u2019, and yet in 65% of these cases, waivers are granted. A total of 25% of the EMEA Management Board have declared pharma interests.
\nhttp:\/\/www.anh-europe.org\/news\/three-eu-drug-regulators-found-with-unacceptable-conflicts-of-interest<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: Dr. Andrew Wakefield, Dr. John Walker-Smith & Dr. Simon Murch Facing Imminent GMC Verdict In Kangaroo Court Trial<\/strong><\/p>\n

\"WakefieldSUPPORT PARENTS\u2019 PETITION AGAINST THE GMC <\/strong><\/p>\n

Assemble at 9:30am Monday 24 May outside the General Medical Council, Regent\u2019s Place, 350 Euston Road, London NW1 3JN, UK. At 11:30 Parents are presenting a petition to the GMC\u2019s Chief Exec & Head of Fitness to Practise, Paul Phillips <\/strong>from parents and doctors around the world in support of Drs Andrew Wakefield, John Walker-Smith and Simon Murch whose fitness to practice hearing concludes on 24 May.<\/strong><\/p>\n

The prosecution is calling for Drs Wakefield and Walker-Smith to be struck from the medical register and for Dr Murch to be suspended. This is despite increasing dissent from the medical community and testimony from parents of the Lancet 12 children that these doctors acted professionally and caringly.<\/strong><\/p>\n

No parent has ever complained to the GMC about the three doctors. Yet, based on one journalist\u2019s complaint, the GMC brought a case against the doctors claiming that research published in The Lancet in 1998 (a case series of 12 children with autism and bowel disease) did not have appropriate ethical approval, that they used the wrong diagnoses to select children for the research and subjected children to invasive procedures not clinically needed. Without regard for academic freedom, the doctors were also blamed for having published research that undermined public health policy supporting MMR vaccine.<\/strong><\/p>\n

The GMC based its case on the erroneous claim that the three authors of the Lancet article failed to follow the terms of the ethical approval granted by the Royal Free Hospital in 1996 (approval 172-96). Yet it is clear from the research programme described in approval 172-96 that it was written after the Lancet research was first carried out (1995-96), and that 172-96 was not the relevant approval for the Lancet case series. The GMC based its unjust case against the doctors on the wrong ethical approval. The three doctors claim that the correct ethical approval was granted in 1995 not 1996. Because of this gross injustice the doctors will most likely lose their right to practice.<\/strong><\/p>\n

The GMC is determined to silence these doctors and ensure they never practice or research again and that they are severely punished for publishing papers that the GMC claim encouraged public criticism of vaccine policy.<\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: Parents \u2018Pimp\u2019 Kids For Swine Flu Test<\/strong><\/p>\n

\"pimp\"Parents of healthy children aged between six months & 10 years in Australia are receiving $300 to test the safety & effectiveness of a new H1N1 vaccine produced by GlaxoSmithKline (GSK). The trial involves two needles, two blood tests and medical monitoring for each child. The cash payments, which could breach national ethical guidelines, will ignite debate over how much should be paid to cover \u201creasonable expenses\u201d of trial participants. <\/strong><\/p>\n

\"GSK-Board\"An industry whistleblower alerted The Sunday Telegraph after some parents were netting $900 by enrolling three children at a time into an H1N1 flu vaccine trial. GPs are also being paid a fee, understood to be at least $200, to refer young patients to the drug-testing clinics. \u201cYou just get parents pimping out their children for a quick buck.\u201d\u00a0\u00a0\u00a0\u00a0 *Photo of <\/strong>GlaxoSmithKline\u2019s<\/strong> Board of Directors<\/strong><\/p>\n

http:\/\/www.news.com.au\/national\/parents-pimp-kids-for-swine-flu-test\/story-e6frfkvr-1225867289202<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: Remote Access Vaccines To Inoculate the Reluctant Herd Now Being Funded. Red Alert! Red Alert! Red Alert!<\/strong><\/p>\n

\"BillGates\"Bill Gates has donated 78 grants of $100,000 each; several toward new vaccine technology development. More effective vaccines being developed include: <\/strong><\/p>\n

1) Sweat-triggered nanoparticles that penetrate the skin through hair follicles and burst upon contact to release vaccines. <\/strong><\/p>\n

2) A \u201cseek-and-destroy\u201d laser vaccine will use existing imaging systems to identify and destroy Leishmania parasites (from the tropics, subtropics & southern Europe) with a targeted laser.<\/strong><\/p>\n

http:\/\/www.gatesfoundation.org\/press-releases\/pages\/grand-challenges-explorations-round-four-winners-100509.aspx<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: World Health Organization Moving To Fast-Track Release Of New Viruses to Pre-Innoculate The Public<\/strong><\/p>\n

\"klaus-stohr\"Dr. Klaus Stohr, former head of the WHO\u2019s global influenza progam, is suggesting pre-vaccinating people, giving them protection against strains that could emerge from nature to trigger future pandemics, to use vaccine BETWEEN pandemics to build up at least partial immunity against some or all of the potential virus subtypes that could cause a pandemic (16 types of hemagglutinins). Stohr is now vice-president of influenza strategy for Novartis Vaccines and Diagnostics, the world\u2019s No. 2 flu vaccine producer which stands to gain significantly if his proposal were to take off.<\/strong><\/p>\n

http:\/\/healthandfitness.sympatico.ca\/News\/ContentPosting?newsitemid=3337898&feedname=CP-HEALTH&show=False&number=0&showbyline=True&subtitle=&detect=&abc=abc&date=True<\/a><\/strong><\/p>\n

On August 6th, 2009. The World Health Organization released this statement from Geneva,<\/strong><\/p>\n

\"WHO2\"\u2018Ways were sought to shorten the time between the emergence of a pandemic virus and the availability of safe and effective vaccines. Different regulatory pathways were assessed, and precautions needed to ensure quality, safety, and effectiveness were set out in detail. Some manufacturers have conducted advance studies using a so-called \u201cmock-up\u201d vaccine. Mock-up vaccines contain an active ingredient for an influenza virus that has not circulated recently in human populations and thus mimics the novelty of a pandemic virus. Such advance studies can greatly expedite regulatory approval.\u2019
\nwww.who.int<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: New Study Vindicates Dr. Andrew Wakefield & Exposes British Medical Journal Lancet Complicity In the Cover-up<\/strong><\/p>\n

\"Doctor+Awaits+Verdict+GMC+Unethical+MMR+Vaccine+lpGsL4zn8nGl\"UPDATE ON DR. ANDREW WAKEFIELD: New independent research presented at the 2010 Pediatric Academic Societies Annual Meeting in Vancouver, Canada confirms unequivocally the findings of Dr Andrew Wakefield\u2019s 1998 Lancet paper of an association between autism and serious gastrointestinal disease in children.<\/strong><\/p>\n

The new study was conducted by the Autism Speaks Autism Treatment Network and covered data from 15 treatment and research centers in the United States and Canada.\u00a0 Of 1185 children aged 2 to18 years with an autistic condition 45% were reported to have GI symptoms. Abdominal pain was most common (59%) followed by constipation (51%), diarrhea (43%), other (40%), nausea (31%) and bloating (26%). Reports of GI symptoms increased with age.\u00a0 Sleep problems occurred in 70% of children with than those without GI symptoms (30%).\u00a0 The problems affected all children regardless of gender, ethnic background or intelligence.
\nhttp:\/\/childhealthsafety.wordpress.com\/2010\/05\/06\/wakefield%E2%80%99s-lancet%C2%A0paper%C2%A0vindicated\/<\/a><\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: Recall of Children\u2019s Tylenol, Motrin, Zyrtec & Benadryl<\/strong><\/p>\n

\"McNeilRaw materials used to make over-the-counter infant\u2019s and children\u2019s medications, which are subject to a massive recall, tested positive for bacterial contamination, according to a Food and Drug Administration inspection report released late Tuesday. <\/strong><\/p>\n

The report, which also found more than a dozen other violations at the facility used to make the products, detailed a series of sloppy manufacturing processes including failure to maintain equipment, properly train employees and correctly weigh ingredients. The report also indicates that the drug maker, Johnson & Johnson\u2019s McNeil Consumer Healthcare subsidiary, failed to investigate \u201c46 consumer complaints regarding foreign materials, dark or black specks,\u201d some dating to June 2009. <\/strong><\/p>\n

\u201cThey\u2019ve had a number of recalls and some observers are starting to question the integrity of the supply chain. The trend we\u2019ve seen is not positive,\u201d said industry analyst Les Funtleyder at Miller Tabak & Co.\u2019
\nhttp:\/\/www.latimes.com\/business\/la-fi-tylenol-20100505,0,3649117.story<\/a><\/strong><\/p>\n

\u2018Food and Drug Administration inspectors found in April that McNeil Consumer Healthcare, which has voluntarily recalled certain lots of its children\u2019s and infants\u2019 Tylenol products, knowingly used bacteria-contaminated materials to make them, a report posted Tuesday by the agency says.\u2019
\nhttp:\/\/www.usatoday.com\/news\/health\/2010-05-04-tylenol-plant_N.htm?csp=34<\/a><\/strong><\/p>\n

\"TylenolFDA REPORT: \u2018McNeil Consumer Healthcare and FDA notified healthcare professionals of a voluntary recall of certain over-the-counter (OTC) Children\u2019s and Infants\u2019 liquid products manufactured in the United States, including Tylenol, Motrin, Zyrtec, and Benadryl products. McNeil Consumer Healthcare is initiating this voluntary recall because some of these products may not meet required quality standards. This recall is not being undertaken on the basis of adverse medical events. However, as a precautionary measure, parents and caregivers should not administer these products to their children. Some of the products included in the recall may contain a higher concentration of active ingredient than is specified; others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles. While potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use.\u2019
\nhttp:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm210442.htm<\/a>
\nhttp:\/\/www.fda.gov\/Safety\/Recalls\/ucm210443.htm<\/a><\/strong><\/p>\n

Product Brands On Recall List \u2013
\nTYLENOL:http:\/\/www.tylenol.com\/page2.jhtml?id=tylenol\/news\/ndc_finder.inc<\/a>
\nMOTRIN:http:\/\/www.motrin.com\/page.jhtml?id=\/motrin\/include\/prd_motrin_ndcfinder.inc<\/a>
\nZYRTEC:http:\/\/zyrtec.com\/econsumer\/zyrtec\/press.view?body=\/zyrtec\/pages\/ndc_finder.jsp<\/a>
\nBENADRIL:http:\/\/www.mcneilproductrecall.com\/page.jhtml?id=\/include\/mpr_ndc_finder.inc<\/a>
\nhttp:\/\/www.mcneilproductrecall.com\/page.jhtml?id=\/include\/new_recall.inc<\/a><\/strong><\/p>\n

FDA FINDINGS ON MCNEIL: LIST OF VIOLATIONS OF SAFETY & PUBLIC TRUST \u2013<\/strong><\/p>\n

A) Failure to investigate \u201c46 consumer complaints regarding foreign materials, dark or black specks,\u201d some dating to June 2009.<\/strong><\/p>\n

B) Failure to maintain equipment, properly train employees and correctly weigh ingredients. <\/strong><\/p>\n

C) 50 variations of infant\u2019s and children\u2019s Tylenol, Motrin, Zyrtec and Benadryl tested positive for bacterial contamination,<\/strong><\/p>\n

D) The report documents \u201cnumerous deficiencies,\u201d including \u201ca failure to sufficiently investigate problems in its manufacturing and in its drugs,\u201d failure to maintain proper testing facilities, and making changes in manufacturing processes without assuring that they would not harm consumers.<\/strong><\/p>\n

E) According to USA Today McNeil KNOWINGLY used bacteria-contaminated materials to make them.<\/strong><\/p>\n

F) The inspection was triggered at least in part by a warning letter sent to a McNeil plant in Puerto Rico in January in connection with another recall involving medications tainted by a chemical found in wooden shipping pallets. A foul odor associated with the chemical temporarily sickened about 70 people. In that letter, FDA cited ongoing concerns with the company\u2019s quality control.<\/strong><\/p>\n

G) The weekend recall was the ninth product recall for McNeil this year, according to FDA figures.<\/strong><\/p>\n

FDA VERDICT: \u2018No decision has been made about what further action, if any, the FDA will take, officials said. Options range from sending a warning letter to seeking criminal penalties.\u2019<\/strong><\/p>\n

\"fda-warning-on-avandia\"The FDA routinely turns a blind eye to Big pharma malfeasance<\/a>. Frequently major violators\u00a0 are given nothing more than a token slap on the wrist; their product then quietly diverted to countries outside the ire of the spotlight \u2013 always accompanied by a Media blackout. <\/strong><\/p>\n

A landmark case \u2013 Bayer Corporation, owned by Nazi sympathizer I.G.Farben<\/a>, were caught red handed distributing Factor 8 <\/a> (a blood clotting agent for Hemophiliacs)\u00a0 tainted with the HIV Aids virus to tens of thousands of hemophiliacs in the United States.\u00a0 The FDA imposed a toothless ban<\/a> with the assurance Bayer would clean up their act. The CEO\u2019s at Bayer avoided any serious recrimination. Within weeks the tainted supplies were quietly shipped for sale to Europe, Asia & Latin America. The vast majority of victims around the world suffered and\/or died in silence. <\/strong>Finally in 1997 Bayer was pinned down in Court<\/a>; with thousands of hemophiliacs involved compensated $100,000 each. However most never saw such token justice.<\/strong><\/p>\n

\u2018Four drug manufacturers whose blood products were said to have infected thousands of hemophiliacs with the virus that causes AIDS in the early 1980\u2019s will pay about $670 million in a settlement approved by a Federal judge. Six thousand hemophiliacs were each to receive $100,000. In an earlier settlement in Japan, AIDS-infected hemophiliacs were paid $450,000 each. The office of Federal District Judge John Grady confirmed today that he had granted oral formal approval to the settlement on Tuesday. The settlement had won preliminary court approval in April 1996. <\/strong><\/p>\n

\"BloodThe settlement was \u201done of the most horrible scenarios that can be imagined,\u201d said Ron Niederman, a spokesman for the Committee of 10 Thousand, which represents the hemophiliacs. \u201dIn light of the damage they caused, the companies are getting off cheap.\u201d <\/strong><\/p>\n

The companies, which admitted no wrongdoing but agreed to settle, were Bayer A.G. of Germany, the Green Cross Corporation of Japan, Rhone-Poulenc Rorer Inc., a French and American company and Baxter International Inc. of Deerfield, Ill.\u2019 <\/strong>
\nhttp:\/\/www.nytimes.com\/1997\/05\/08\/business\/4-drug-companies-ordered-to-pay-hemophiliacs.html<\/a><\/strong><\/p>\n

\u2018The FDA, especially in the area of antidepressants, has long been seen by much of the scientific community as compromised by drug company influence and it is decreasingly recognized as a serious regulatory agency. In a 1991 FDA \u201cblue ribbon\u201d panel investigating the association between Prozac-type antidepressants and violence, five of the nine FDA panel doctors had ties to pharmaceutical corporations. The panel voted not to require these antidepressants to display a violence warning label. This\u00a0 was aided by Paul Leber, director of the FDA\u2019s Division of Neuropharma- cological Drug Products, who in the late 1990s left the FDA to direct a consulting firm that specializes in advising pharmaceutical companies that are attempting to gain FDA approval for new psychiatric drugs. The revolving door of employment between the FDA and Big Pharma resembles other governmental-industrial arrangements where regulatory favors routinely result in future industry income. In 2001 The Lancet, Great Britain\u2019s respected medical journal, described the FDA as a \u201cservant of industry.\u201d<\/strong><\/p>\n

Before approving a drug, the FDA does no research on that drug. Instead, the FDA evaluates studies handed to them by the pharmaceutical company that created the drug. Despite repeated evidence of untrustworthiness and outright fraud, the FDA continues to trust Big Pharma data.\u2019
\nhttp:\/\/brucelevine.net\/zmag-behindpaxilscandals-levinepr0405.htm<\/a><\/strong><\/p>\n

\u2018Even if McNeil had been operating up to proper standards, many of its children\u2019s formulations are still filled with questionable chemical ingredients like aspartame, high-fructose corn syrup, sucralose (Splenda), artificial colors and preservatives, and even parabens, all of which are approved by the FDA for use in children\u2019s and infants\u2019 formulas.<\/strong><\/p>\n

The shocking truth is that, even in their approved and \u201csafe\u201d forms, most OTC children\u2019s medicines are nothing more than dangerous chemical cocktails being peddled as medicine. They\u2019re filled with so much harmful garbage that they can hardly be considered beneficial. Most of them are outright useless. These OTC children\u2019s medicines are the quackery of modern medicine.\u2019 Mike Adams, Natural News<\/strong>
\nhttp:\/\/www.naturalnews.com\/028732_Tylenol_recall.html<\/a><\/strong><\/p>\n

\"Gluco\"\u201cTylenol uses up glutathione (GSH) stores and metabolites of acetaminophen accumulates causing direct damage to liver cells. You want their glutathione levels to be optimum because GSH main purpose is for detoxifying and eliminating heavy metals and other environmental toxins. It is essential for the function of the gut, maintains Vitamins C and E, maintains mitochondrial integrity, protects against intracellular viruses and so much more. Anything that compromises the level of glutathione needed to maintain health like Tylenol should be avoided.\u201d Brian Jepson, MD<\/a><\/strong><\/p>\n

\u2018Acetaminophen overdose is the leading cause for calls to Poison Control Centers (>100,000\/year) and accounts for more than 56,000 emergency room visits, 2,600 hospitalizations, and an estimated 458 deaths due to acute liver failure each year. Data from the U.S. Acute Liver Failure Study Group registry of more than 700 patients with acute liver failure across the United States implicates acetaminophen poisoning in nearly 50% of all acute liver failure in this country. Available in many single or combination products, acetaminophen produces more than 1 billion US dollars in annual sales for Tylenol products alone. It is heavily marketed for its safety compared to nonsteroidal analgesics. By enabling self-diagnosis and treatment of minor aches and pains, its benefits are said by the Food and Drug Administration to outweigh its risks. It still must be asked: Is this amount of injury and death really acceptable for an over-the-counter pain reliever?\u2019
\nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15239078<\/a><\/strong><\/p>\n

\u2018People who take NSAIDs<\/a> for prolonged periods of time can develop several GI side effects<\/a>, such as stomach aches, indigestion, or even ulcers. Ulcers can eventually lead to GI bleeding or may even perforate, spilling the contents of the stomach or small intestine into the sterile abdominal cavity. Every time they come in with bleeding, they have a 10% chance of dying.\u2019 Dr. Joseph Mercola<\/strong><\/p>\n

\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014<\/strong><\/p>\n

BREAKING NEWS: Australian Flu Vaccine Scandal Unfolding<\/strong><\/p>\n

\"Panvax\"WHAT IS THE REAL REASON SO MANY YOUNG CHILDREN ARE BEING ADVERSELY AFFECTED BY AUSTRALIA\u2019S 2010 FLU SHOT COCKTAIL?
\n<\/strong><\/p>\n

CONTENTS: A STAGGERING 50 MICROGRAMS OF MERCURY IN THE SHOT (MOST CURRENT MULTI-DOSE VACCINES AVG 2.5), H1N1 SUBUNITS (LIVE VIRUS SLIGHTLY MODIFIED WITH DETERGENT), NEOMYCIN & POLYMYXIN (ANTIBIOTICS ASSOCIATED WITH KIDNEY FAILURE), BETA-PROPLOLACTONE (A KNOWN HUMAN CARCINOGEN). <\/strong><\/p>\n

Most multi-dose vaccines currently average 2.5 micrograms of Thimerosal Mercury. Based on EPA standards this is considered a safe level of exposure for a 250 pound adult. Australia\u2019s 2010 Flu vaccine Panvax contains 50 micrograms of Thimerosal; technically a safe level of exposure for a 5000 pound adult. Unless you were born a Mack Truck this is tantamount to attempted murder. <\/strong>Time for the Australian community to rise up against this tyranny with a massive Class Action law suit.<\/strong><\/p>\n

\u2018Included in the ingredients are two antibiotics, Neomycin and Polymyxin B Sulphate. Both are noted for serious side effects, predominantly kidney failure. It is warned both these antibiotics not be used by pregnant women. Neomycin is in the FDA pregnancy category D. This means that it is known to be harmful to an unborn baby. In the \u201cfirst tier\u201d of candidates to receive this unregistered, unapproved vaccine, pregnant women are on top of the list. Beta-Propiolactone is another listed ingredient. Ranked as one of the most hazardous compounds (worst 10%) to humans and \u201creasonably expected to be a human carcinogen\u201d (International Agency for Research on Cancer \u2013 IARC, 1999). \u0392eta-Propiolactone is a disinfectant. Panvax is formulated using chick embryos (Ovalbumin). People who suffer allergy to eggs or anaphylactic reactions may experience problems.\u2019
\nhttp:\/\/contribute.abc.net.au\/_Panvax\/blog\/718273\/32422.html<\/a><\/strong><\/p>\n

\u2018The Australian is reporting that clinical tests were never carried out on this particular vaccine, which was a first-time combination of seasonal flu with Panvax, a vaccine against the H1N1 strain. Australia was the first country to use this type of vaccine, the report said. Panvax was tested on 400 children before its release last year, but the combined shot was not subjected to any clinical trials.\u2019
\nhttp:\/\/www.newsinferno.com\/archives\/19877<\/a><\/strong><\/p>\n

\"WHO\"WORLD HEALTH ORGANIZATION INFLUENZA VACCINE DIRECTIVE FOR 2010 <\/strong>(WHO guidelines are typically adhered to by most Governments)<\/strong>: It is recommended that vaccines for use in the 2010 influenza season (southern hemisphere winter) contain the following \u2013
\n<\/strong><\/p>\n

1) an A\/California\/7\/2009 (H1N1)-like virus;
\n2) an A\/Perth\/16\/2009 (H3N2)-like virus;
\n3) a B\/Brisbane\/60\/2008-like virus.<\/strong><\/p>\n

http:\/\/www.who.int\/csr\/disease\/influenza\/recommendations2010south\/en\/index.html<\/a>
\nhttp:\/\/www.who.int\/csr\/disease\/influenza\/200909_Recommendation.pdf<\/a><\/strong><\/p>\n

EARLY VACCINE TRAUMA REPORT FROM AUSTRALIA (HIGH TEMPERATURES & FEBRILE CONVULSIONS<\/a>) \u2013 The Australian Health Minister, Kim Hames, says 45 children have been taken to hospital suffering high temperatures and febrile convulsions after receiving the vaccination. Dr Hames says the program will be suspended until the department finishes its investigation. He says parents who have had their children vaccinated should take precautions.\u201dIf it\u2019s longer than 12 hours ago then there is no risk. But if it\u2019s in the last 12 hours they should make sure that they give their child paracetamol and then take every effort to make sure that the temperature of their child is settled.\u201d
\nhttp:\/\/www.abc.net.au\/news\/stories\/2010\/04\/22\/2880521.htm?site=news<\/a><\/strong><\/p>\n

Febrile convulsions occur in young children when there is a rapid increase in their body temperature. It affects up to 1 in 20 children between the ages of one and four but can affect children between six months and about five years old.<\/strong><\/p>\n